GW
IBB icon

GW & Wade’s iShares Biotechnology ETF IBB Stock Holding History

GW & Wade’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$2.11M Sell
15,515
-640
-4% -$78.1K 0.07% 172
2023
Q3 		$1.98M Buy
16,155
+211
+1% +$26.8K 0.07% 162
2023
Q2 		$2.02M Buy
15,944
+366
+2% +$47.5K 0.07% 156
2023
Q1 		$2.01M Buy
15,578
+120
+0.8% +$15.7K 0.08% 151
2022
Q4 		$2.03M Buy
15,458
+39
+0.3% +$5.04K 0.08% 147
2022
Q3 		$1.8M Buy
15,419
+805
+6% +$100K 0.09% 139
2022
Q2 		$1.72M Buy
14,614
+140
+1% +$16.6K 0.08% 151
2022
Q1 		$1.89M Buy
14,474
+250
+2% +$32.6K 0.08% 138
2021
Q4 		$2.17M Buy
14,224
+270
+2% +$41.8K 0.09% 128
2021
Q3 		$2.26M Buy
13,954
+399
+3% +$67.1K 0.11% 123
2021
Q2 		$2.22M Buy
13,555
+893
+7% +$138K 0.11% 122
2021
Q1 		$1.91M Buy
12,662
+5,045
+66% +$801K 0.1% 120
2020
Q4 		$1.15M Buy
7,617
+5,342
+235% +$763K 0.07% 132
2020
Q3 		$308K Buy
+2,275
New +$309K 0.02% 193
2019
Q2 		– Sell
-1,953
Closed -$218K – 238
2019
Q1 		$218K Sell
1,953
-300
-13% -$32.9K 0.02% 211
2018
Q4 		$217K Buy
2,253
+1
+0% +$106 0.02% 206
2018
Q3 		$275K Buy
2,252
+1
+0% +$118 0.03% 201
2018
Q2 		$247K Hold
2,251
– – 0.03% 212
2018
Q1 		$240K Hold
2,251
– – 0.03% 207
2017
Q4 		$240K Buy
2,251
+43
+2% +$4.6K 0.03% 195
2017
Q3 		$246K Hold
2,208
– – 0.03% 207
2017
Q2 		$228K Hold
2,208
– – 0.03% 207
2017
Q1 		$216K Buy
+2,208
New +$211K 0.03% 221
2016
Q4 		– Sell
-2,214
Closed -$214K – 231
2016
Q3 		$214K Buy
+2,214
New +$211K 0.04% 211
2015
Q3 		– Sell
-1,689
Closed -$208K – 231
2015
Q2 		$208K Sell
1,689
-81
-5% -$9.7K 0.04% 217
2015
Q1 		$203K Sell
1,770
-489
-22% -$53.9K 0.04% 226
2014
Q4 		$228K Buy
+2,259
New +$220K 0.06% 123

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

GW & Wade's IBB Position: Q4 2023 in Review

GW & Wade reduced its iShares Biotechnology ETF (IBB) stake by 4% in Q4 2023, selling an estimated $78.1K and leaving 15,515 shares worth $2.11M. The position accounts for 0.07% of the portfolio, ranked #172.

GW & Wade first reported a position in IBB in Q4 2014 and has held it in 27 quarters since. The position peaked at $2.26M in Q3 2021. 874 funds tracked by Wall St. Rank hold IBB as of Q4 2023.

  • GW & Wade held 15,515 shares of iShares Biotechnology ETF worth $2.11M as of Q4 2023.
  • GW & Wade sold 640 iShares Biotechnology ETF shares in Q4 2023, an estimated $78.1K.
  • iShares Biotechnology ETF made up 0.07% of GW & Wade's portfolio in Q4 2023, its #172 holding.
  • GW & Wade first reported a position in iShares Biotechnology ETF in Q4 2014 and has held it in 27 quarters since.
  • GW & Wade's iShares Biotechnology ETF position peaked at $2.26M in Q3 2021.
  • 874 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2023.

Based on GW & Wade's 13F filing for Q4 2023, filed 8 Feb 2024.